XML 49 R36.htm IDEA: XBRL DOCUMENT v3.25.1
Fair Value of Assets and Liabilities (Tables)
12 Months Ended
Dec. 31, 2024
Fair Value Disclosures [Abstract]  
Fair Value, Assets and Liabilities Measured on Recurring Basis The tables below present the balances of assets and liabilities reported at fair value on a recurring basis, as of the dates indicated.
 December 31, 2024
Level 1Level 2Level 3Netting(1)Total
(in thousands)
Fixed maturities, available-for-sale:
U.S. Treasury securities and obligations of U.S. government authorities and agencies$$1,099,241 $$$1,099,241 
Obligations of U.S. states and their political subdivisions541,066 541,066 
Foreign government securities309,686 648 310,334 
U.S. corporate public securities13,238,428 13,238,428 
U.S. corporate private securities4,996,400 757,697 5,754,097 
Foreign corporate public securities3,692,124 6,727 3,698,851 
Foreign corporate private securities4,906,450 435,183 5,341,633 
Asset-backed securities(2)3,126,089 624,574 3,750,663 
Commercial mortgage-backed securities820,457 75,318 895,775 
Residential mortgage-backed securities356,072 356,072 
Subtotal33,086,013 1,900,147 34,986,160 
Market risk benefit assets2,637,363 2,637,363 
Fixed maturities, trading3,778,760 66,285 3,845,045 
Equity securities2,587,791 15,514 20,515 2,623,820 
Short-term investments390,745 105,540 496,285 
Cash equivalents2,851,250 33 2,851,283 
Other invested assets(4)2,302 15,330,249 143 (15,308,195)24,499 
Reinsurance recoverables and deposit receivables645,193 645,193 
Receivables from parent and affiliates169,072 351,390 520,462 
Subtotal excluding separate account assets2,590,093 55,621,603 5,726,609 (15,308,195)48,630,110 
Separate account assets(5)(6)273,288 111,415,717 10,547 111,699,552 
Total assets$2,863,381 $167,037,320 $5,737,156 $(15,308,195)$160,329,662 
Market risk benefit liabilities$$$4,281,244 $$4,281,244 
Policyholders' account balances12,624,585 12,624,585 
Payables to parent and affiliates27,232,920 (23,617,643)3,615,277 
Other liabilities7,988 1,274 31 (1,943)7,350 
Total liabilities$7,988 $27,234,194 $16,905,860 $(23,619,586)$20,528,456 
 December 31, 2023
 Level 1Level 2Level 3Netting(1)Total
 (in thousands)
Fixed maturities, available-for-sale:
U.S. Treasury securities and obligations of U.S. government authorities and agencies$$975,287 $$$975,287 
Obligations of U.S. states and their political subdivisions776,627 776,627 
Foreign government securities281,304 682 281,986 
U.S. corporate public securities9,495,912 9,495,912 
U.S. corporate private securities4,476,258 513,236 4,989,494 
Foreign corporate public securities1,698,965 7,129 1,706,094 
Foreign corporate private securities4,137,004 493,978 4,630,982 
Asset-backed securities(2)1,928,428 99,122 2,027,550 
Commercial mortgage-backed securities773,663 78,115 851,778 
Residential mortgage-backed securities396,070 396,070 
Subtotal24,939,518 1,192,262 26,131,780 
Market risk benefit assets2,367,243 2,367,243 
Fixed maturities, trading2,762,398 34,048 2,796,446 
Equity securities(3)790,346 11,285 28,709 830,340 
Short-term investments31,879 280,228 1,759 313,866 
Cash equivalents447,396 1,196,729 1,644,125 
Other invested assets(4)23,432 9,022,304 (9,028,019)17,718 
Reinsurance recoverables and deposit receivables(7)(8)192,642 192,642 
Receivables from parent and affiliates147,984 147,984 
Subtotal excluding separate account assets1,293,053 38,360,446 3,816,664 (9,028,019)34,442,144 
Separate account assets(5)(6)176,239 113,747,569 5,985 113,929,793 
Total assets$1,469,292 $152,108,015 $3,822,649 $(9,028,019)$148,371,937 
Market risk benefit liabilities(8)$$$5,156,858 $$5,156,858 
Policyholders' account balances(8)7,697,627 7,697,627 
Payables to parent and affiliates21,239,770 (18,588,647)2,651,123 
Other liabilities(7)8,032 225 (8,032)225 
Total liabilities$8,032 $21,239,995 $12,854,485 $(18,596,679)$15,505,833 
(1)“Netting” amounts represent cash collateral of $(8,311) million and $(9,569) million as of December 31, 2024 and 2023, respectively, and the impact of offsetting asset and liability positions held with the same counterparty, subject to master netting agreements.
(2)Includes credit-tranched securities collateralized by loan obligations, home equity loans, auto loans and education loans.
(3)Equity securities excluded from the fair value hierarchy include a fund for which fair value is measured at net asset value ("NAV") per share (or its equivalent) as a practical expedient. As of December 31, 2023, the fair value of this investment was $14.6 million.
(4)Other invested assets excluded from the fair value hierarchy include certain hedge funds, private equity funds and other funds for which fair value is measured at NAV per share (or its equivalent) as a practical expedient. At December 31, 2024 and 2023, the fair value of such investments was $44 million and $67 million, respectively.
(5)Separate account assets represent segregated funds that are invested for certain customers. Investment risks associated with market value changes are borne by the customers, except to the extent of minimum guarantees made by the Company with respect to certain accounts. Separate account liabilities are not included in the above table as they are reported at contract value and not fair value in the Company's Consolidated Statements of Financial Position.
(6)Separate account assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate, hedge funds and a corporate owned life insurance fund. At December 31, 2024 and 2023, the fair value of such investments was $6,444 million and $5,259 million, respectively.
(7)Prior period amounts have been updated to conform to current period presentation.
Fair Value Inputs, Assets and Liabilities, Quantitative Information The tables below present quantitative information regarding significant internally-priced Level 3 assets and liabilities.
 December 31, 2024
 Fair Value    Valuation  
Techniques
Unobservable 
Inputs  
Minimum  MaximumWeighted
Average
Impact of 
Increase in Input on Fair Value(1)(2)
 (in thousands)
Assets:
Corporate securities(3)$1,130,627 Discounted cash flowDiscount rate2.15 %20 %11.15 %Decrease
Market ComparablesEBITDA multiples(4)5.0 X5.0 X5.0 XIncrease
LiquidationLiquidation value75.00 %75.00 %75.00 %Increase
Asset-backed securities$90,370  Discounted cash flow  Discount rate 2.30 %10.70 %6.18 %Decrease
Commercial mortgage-backed securities$75,318 Discounted cash flowLiquidity premium1.00 %1.00 %1.00 %Decrease
Market risk benefit assets(5)$2,637,363 Discounted cash flowLapse rate(6)%20 %Increase
Spread over SOFR(7)0.29 %1.79 %Increase
Utilization rate(8)37 %94 %Decrease
Withdrawal rateSee table footnote (9) below.
Mortality rate(10)%16 %Increase
Equity volatility curve16 %25 %Decrease
Reinsurance recoverables and deposit receivables(11)$645,193 Discounted cash flowLapse rate(6)%80 %Decrease
Spread over SOFR(7)0.29 %1.71 %Decrease
Option budget(13)(1)%%Increase
Receivables from parent and affiliates$328,001 LiquidationLiquidation value100 %100 %100 %Increase
Liabilities:
Market risk benefit liabilities(5)$4,281,244 Discounted cash flowLapse rate(6)%20 %Decrease
Spread over SOFR(7)0.29 %1.79 %Decrease
Utilization rate(8)37 %94 %Increase
Withdrawal rateSee table footnote (9) below.
Mortality rate(10)%16 %Decrease
Equity volatility curve16 %25 %Increase
Policyholders' account balances(12)$12,624,585 Discounted cash flowLapse rate(6)%80 %Decrease
Spread over SOFR(7)0.29 %1.73 %Decrease
Mortality rate(10)%23 %Decrease
Option budget(13)(1)%%Increase
 December 31, 2023
 Fair ValueValuation 
Techniques
Unobservable 
Inputs   
MinimumMaximumWeighted
Average
Impact of 
Increase in Input on Fair Value(1)(2)
 (in thousands)
Assets:
Corporate securities(3)$81,635 Discounted cash flowDiscount rate6.98 %20 %9.73 %Decrease
LiquidationLiquidation Value63.62 %63.62 %63.62 %Increase
Commercial mortgage-backed securities$78,115 Discounted cash flowLiquidity premium0.60 %0.75 %0.71 %Decrease
Market risk benefit assets(5)$2,367,243 Discounted cash flowLapse rate(6)%20 %Increase
Spread over SOFR(7)0.41 %1.91 %Increase
Utilization rate(8)38 %95 %Decrease
Withdrawal rateSee table footnote (9) below.
Mortality rate(10)%15 %Increase
Equity volatility curve15 %25 %Decrease
Reinsurance recoverables and deposit receivables(11)(14)(15)$192,642 Discounted cash flowLapse rate(6)%80 %Increase
Spread over SOFR(7)(14)0.41 %1.82 %Increase
Option budget(13)(1)%%Decrease
Liabilities:
Market risk benefit liabilities(5)(15)$5,156,858 Discounted cash flowLapse rate(6)%20 %Decrease
Spread over SOFR(7)0.41 %1.91 %Decrease
Utilization rate(8)38 %95 %Increase
Withdrawal rateSee table footnote (9) below.
Mortality rate(10)%15 %Decrease
Equity volatility curve15 %25 %Increase
Policyholders' account balances(12)(15)$7,697,627 Discounted cash flowLapse rate(6)%80 %Decrease
Spread over SOFR(7)0.41 %1.85 %Decrease
Mortality rate(10)%23 %Decrease
Option budget(13)(1)%%Increase
    
(1)Conversely, the impact of a decrease in input would have the opposite impact on fair value as that presented in the table.
(2)Directional impacts for MRB assets and liabilities are associated with the directional impacts of direct and assumed MRBs.
(3)Includes assets classified as fixed maturities, available-for-sale and fixed maturities, trading.
(4)Represents multiples of earnings before interest, taxes, depreciation and amortization ("EBITDA"), and are amounts used when the Company has determined that market participants would use such multiples when valuing the investments.
(5)Market risk benefits primarily represent fair value for all living benefit guarantees including accumulation, withdrawal and income benefits. Since the valuation methodology for these assets and liabilities uses a range of inputs that vary at the contract level over the cash flow projection period, presenting a range, rather than weighted average, is a more meaningful representation of the unobservable inputs used in the valuation.
(6)Lapse rates for contracts with living benefit guarantees are adjusted at the contract level based on the in-the-moneyness of the living benefit and reflect other factors, such as the applicability of any surrender charges. Lapse rates are reduced when contracts are more in-the-money. Lapse rates for contracts with index-linked crediting guarantees may be adjusted at the contract level based on the applicability of any surrender charges, product type, and market related factors such as interest rates. Lapse rates are also generally assumed to be lower for the period where surrender charges apply. For any given contract, lapse rates vary throughout the period over which cash flows are projected for the purposes of valuing these balances.
(7)The spread over the SOFR swap curve represents the premium added to the proxy for the risk-free rate (SOFR) to reflect the Company's estimates of rates that a market participant would use to value the living benefits in both the accumulation and payout phases and index-linked interest crediting guarantees as of December 31, 2024 and 2023, respectively. This spread includes an estimate of NPR, which is the risk that the obligation will not be fulfilled by the Company. NPR is primarily estimated by utilizing the credit spreads associated with issuing funding agreements, adjusted for any illiquidity risk premium. In order to reflect the financial strength ratings of the Company, credit spreads associated with funding agreements, as opposed to credit spread associated with debt, are utilized in developing this estimate because funding agreements are insurance liabilities and are therefore senior to debt. Effective April 2023, the Company entered into an agreement with The Ohio National Life Insurance Company, now known as AuguStar Life Insurance Company ("AuguStar"), an affiliate of Constellation Insurance Holdings, Inc., to reinsure approximately $10 billion of account values of PDI traditional variable annuity contracts with guaranteed living benefits. See Note 11 for additional information regarding this transaction. As a result of this transaction, a ceded MRB asset balance was established to fair value the reinsurance reimbursements to the Company. The establishment of the fair value also required an estimate of NPR for AuguStar, which may differ from the Company's; however, the NPR spreads for AuguStar were developed using a methodology similar to that of the Company.
(8)The utilization rate assumption estimates the percentage of contracts that will utilize the benefit during the contract duration and begin lifetime withdrawals at various time intervals from contract inception. The remaining contractholders are assumed to either begin lifetime withdrawals immediately or never utilize the benefit. Utilization assumptions may vary by product type, tax status and age. The impact of changes in these assumptions is highly dependent on the product type, the age of the contractholder at the time of the sale, and the timing of the first lifetime income withdrawal. Range reflects the utilization rate for the vast majority of business with living benefits.
(9)The withdrawal rate assumption estimates the magnitude of annual contractholder withdrawals relative to the maximum allowable amount under the contract. These assumptions vary based on the age of the contractholder, the tax status of the contract and the duration since the contractholder began lifetime withdrawals. As of December 31, 2024 and 2023, the minimum withdrawal rate assumption is 78% and 81%, respectively. As of December 31, 2024 and 2023, the maximum withdrawal rate assumption may be greater than 100%. The fair value of the liability will generally increase the closer the withdrawal rate is to 100% and decrease as the withdrawal rate moves further away from 100%.
(10)The range reflects the mortality rates for the vast majority of business with living benefits and other contracts, with policyholders ranging from 50 to 90 years old. While the majority of living benefits have a minimum age requirement, certain other contracts do not have an age restriction. This results in contractholders with mortality rates approaching 0% for certain benefits. Mortality rates may vary by product, age and duration. A mortality improvement assumption is also incorporated into the overall mortality table.
(11)Includes deposit assets related to reinsurance agreements using deposit method of accounting and modified coinsurance agreements, which include amounts representing the fair value of embedded derivative instruments associated with the index-linked features of certain annuity products.
(12)Policyholders’ account balances primarily represent general account liabilities for the index-linked interest credited on certain of the Company’s life and annuity products that are accounted for as embedded derivatives. Since the valuation methodology for these liabilities uses a range of inputs that vary at the contract level over the cash flow projection period, presenting a range, rather than a weighted average, is a more meaningful representation of the unobservable inputs used in the valuation.
(13)Option budget estimates the expected long-term cost of options used to hedge exposures associated with equity price and interest rate changes. The level of option budget determines future costs of the options, which impacts the growth in account value and the valuation of embedded derivatives.
(14)Prior period amounts have been updated to conform to current period presentation.
(15)Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information.
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation The following tables describe changes in fair values of Level 3 assets and liabilities as of the dates indicated, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held at the end of their respective periods (excluding MRBs disclosed in Note 10). When a determination is made to classify assets and liabilities within Level 3, the determination is based on significance of the unobservable inputs in the overall fair value measurement. All transfers are based on changes in the observability of the valuation inputs, including the availability of pricing service information that the Company can validate. Transfers into Level 3 are generally the result of unobservable inputs utilized within valuation methodologies and the use of indicative broker quotes for assets that were previously valued using observable inputs. Transfers out of Level 3 are generally due to the use of observable inputs in valuation methodologies as well as the availability of pricing service information for certain assets that the Company can validate.
Year Ended December 31, 2024(6)
Fair Value, beginning of periodTotal realized and unrealized gains (losses)PurchasesSalesIssuancesSettlementsOther(1)Transfers into Level 3(7)Transfers out of Level 3(7)Fair Value, end of periodUnrealized gains (losses) for assets still held(2)
(in thousands)
Fixed maturities, available-for-sale:
Foreign government$682 $(34)$$$$$$$$648 $(44)
Corporate securities(3)1,014,343 (69,658)1,172,201 (702,073)(183,577)(64,672)33,043 1,199,607 (61,011)
Structured securities(4)177,237 (5,386)771,208 (40,508)(96,067)65,480 34,578 (206,650)699,892 (3,394)
Other assets:
Fixed maturities, trading34,048 (9,654)261,968 (52)(2,261)18,842 (236,606)66,285 (9,705)
Equity securities28,709 (2,135)273 (6,120)(6,332)6,120 20,515 (230)
Other invested assets142 143 142 
Short-term investments1,759 1,539 117,046 (13,113)(1,488)(203)105,540 321 
Cash equivalents(41)744 (65)(605)33 (41)
Reinsurance recoverables and deposit receivables (5)192,642 26,029 333,291 93,231 645,193 (122,807)
Separate account assets5,985 457 5,823 (2,050)(126)458 10,547 457 
Receivables from parent and affiliates90 418,916 (51,199)(16,417)351,390 90 
Liabilities:
Policyholders' account balances(5)(7,697,627)(2,687,101)(2,286,786)46,929 (12,624,585)1,254,144 
Other liabilities(31)(31)(31)
Year Ended December 31, 2024
Total realized and unrealized gains (losses)Unrealized gains (losses) for assets still held(2)
Realized investment gains (losses), netOther income (loss)Interest credited to policyholders' account balancesIncluded in other comprehensive income (loss)Net investment incomeRealized investment gains (losses), netOther income (loss)Interest credited to policyholders' account balancesIncluded in other comprehensive income (loss)
(in thousands)
Fixed maturities, available-for-sale$(54,924)$$$(19,313)$(841)$(40,765)$$$(23,684)
Other assets:
Fixed maturities, trading(9,661)(9,705)
Equity securities(2,135)(230)
Other invested assets142 142 
Short-term investments1,142 385 12 (64)385 
Cash equivalents(41)(41)
Reinsurance recoverables and deposit receivables26,029 (122,807)
Separate account assets457 457 
Receivables from parent and affiliates90 90 
Liabilities:
Policyholders' account balances(2,687,101)1,254,144 
Other liabilities(31)(31)
Year Ended December 31, 2023(6)
Fair Value, beginning of periodTotal realized and unrealized gains (losses)PurchasesSalesIssuancesSettlementsOther(1)Transfers into Level 3(7)Transfers out of Level 3(7)Fair Value, end of periodUnrealized gains (losses) for assets still held(2)
(in thousands)
Fixed maturities, available-for-sale:
Foreign government$724 $(42)$$$$$$$$682 $(53)
Corporate securities(3)507,496 85 567,936 (39,722)(130,688)3,129 117,671 (11,564)1,014,343 (973)
Structured securities(4)104,724 (4,442)241,159 (37)(2,147)(2,222)4,537 (164,335)177,237 (4,298)
Other assets:
Fixed maturities, trading1,083 36,284 2,931 (6,250)34,048 1,225 
Equity securities28,593 (928)2,531 (1,487)28,709 (928)
Other invested assets
Short-term investments16,945 2,573 4,922 (21,322)(1,359)1,759 
Reinsurance recoverables and deposit receivables(5)(8)(9)115,886 (104,596)183,716 (2,364)192,642 (119,067)
Separate account assets4,645 408 2,216 (1,124)(160)5,985 406 
Liabilities:
Policyholders' account balances(5)(9)(3,502,096)(2,649,136)(1,653,026)106,631 (7,697,627)(368,507)
Year Ended December 31, 2023
Total realized and unrealized gains (losses)Unrealized gains (losses) for assets still held(2)
Realized investment gains (losses), netOther income (loss)Interest credited to policyholders' account balancesIncluded in other comprehensive income (loss)Net investment incomeRealized investment gains (losses), netOther income (loss)Interest credited to policyholders' account balancesIncluded in other comprehensive income (loss)
(in thousands)
Fixed maturities, available-for-sale$(2,081)$$$(2,808)$490 $(2,904)$$$(2,420)
Other assets:
Fixed maturities, trading1,080 1,225 
Equity securities(928)(928)
Other invested assets
Short-term investments1,857 (73)789 
Reinsurance recoverables and deposit receivables(8)(9)(104,596)(119,067)
Separate account assets408 406 
Liabilities:
Policyholders' account balances(9)(2,649,136)(368,507)
Year Ended December 31, 2022
Total realized and unrealized gains (losses)Unrealized gains (losses) for assets still held(2)
Realized investment gains (losses), netOther income (loss)Interest credited to policyholders' account balancesIncluded in other comprehensive income (loss)Net investment incomeRealized investment gains (losses), netOther income (loss)Interest credited to policyholders' account balancesIncluded in other comprehensive income (loss)
(in thousands)
Fixed maturities, available-for-sale$(16,829)$$$(56,470)$(242)$(14,416)$$$(59,239)
Other assets:
Equity securities(3,310)(3,872)
Short-term investments77 73 (36)73 
Reinsurance recoverables and deposit receivables(9)111,382 115,303 
Separate account assets(70)(70)
Liabilities:
Policyholders' account balances(409,912)(289,548)
(1)"Other" includes additional activity not allocated to the specific categories within the rollforward of Level 3 Assets and Liabilities.
(2)Unrealized gains or losses related to assets still held at the end of the period do not include amortization or accretion of premiums and discounts.
(3)Includes U.S. corporate private, foreign corporate public, foreign corporate private, and foreign government bonds.
(4)Includes asset-backed and commercial mortgage-backed securities.
(5)Purchases/issuances and settlements for Policyholders' account balances and Reinsurance recoverables and deposit receivables are presented net in the rollforward.
(6)Excludes MRB assets of $2,637 million and $2,367 million and MRB liabilities of $4,281 million and $5,157 million as of December 31, 2024 and 2023, respectively. See Note 10 for additional information.
(7)Transfers into or out of Level 3 are generally reported at the value as of the beginning of the quarter in which the transfers occur for any such positions still held at the end of the quarter.
(8)Prior period amounts have been updated to conform to current period presentation.
(9)Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information.
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation The following tables describe changes in fair values of Level 3 assets and liabilities as of the dates indicated, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held at the end of their respective periods (excluding MRBs disclosed in Note 10). When a determination is made to classify assets and liabilities within Level 3, the determination is based on significance of the unobservable inputs in the overall fair value measurement. All transfers are based on changes in the observability of the valuation inputs, including the availability of pricing service information that the Company can validate. Transfers into Level 3 are generally the result of unobservable inputs utilized within valuation methodologies and the use of indicative broker quotes for assets that were previously valued using observable inputs. Transfers out of Level 3 are generally due to the use of observable inputs in valuation methodologies as well as the availability of pricing service information for certain assets that the Company can validate.
Year Ended December 31, 2024(6)
Fair Value, beginning of periodTotal realized and unrealized gains (losses)PurchasesSalesIssuancesSettlementsOther(1)Transfers into Level 3(7)Transfers out of Level 3(7)Fair Value, end of periodUnrealized gains (losses) for assets still held(2)
(in thousands)
Fixed maturities, available-for-sale:
Foreign government$682 $(34)$$$$$$$$648 $(44)
Corporate securities(3)1,014,343 (69,658)1,172,201 (702,073)(183,577)(64,672)33,043 1,199,607 (61,011)
Structured securities(4)177,237 (5,386)771,208 (40,508)(96,067)65,480 34,578 (206,650)699,892 (3,394)
Other assets:
Fixed maturities, trading34,048 (9,654)261,968 (52)(2,261)18,842 (236,606)66,285 (9,705)
Equity securities28,709 (2,135)273 (6,120)(6,332)6,120 20,515 (230)
Other invested assets142 143 142 
Short-term investments1,759 1,539 117,046 (13,113)(1,488)(203)105,540 321 
Cash equivalents(41)744 (65)(605)33 (41)
Reinsurance recoverables and deposit receivables (5)192,642 26,029 333,291 93,231 645,193 (122,807)
Separate account assets5,985 457 5,823 (2,050)(126)458 10,547 457 
Receivables from parent and affiliates90 418,916 (51,199)(16,417)351,390 90 
Liabilities:
Policyholders' account balances(5)(7,697,627)(2,687,101)(2,286,786)46,929 (12,624,585)1,254,144 
Other liabilities(31)(31)(31)
Year Ended December 31, 2024
Total realized and unrealized gains (losses)Unrealized gains (losses) for assets still held(2)
Realized investment gains (losses), netOther income (loss)Interest credited to policyholders' account balancesIncluded in other comprehensive income (loss)Net investment incomeRealized investment gains (losses), netOther income (loss)Interest credited to policyholders' account balancesIncluded in other comprehensive income (loss)
(in thousands)
Fixed maturities, available-for-sale$(54,924)$$$(19,313)$(841)$(40,765)$$$(23,684)
Other assets:
Fixed maturities, trading(9,661)(9,705)
Equity securities(2,135)(230)
Other invested assets142 142 
Short-term investments1,142 385 12 (64)385 
Cash equivalents(41)(41)
Reinsurance recoverables and deposit receivables26,029 (122,807)
Separate account assets457 457 
Receivables from parent and affiliates90 90 
Liabilities:
Policyholders' account balances(2,687,101)1,254,144 
Other liabilities(31)(31)
Year Ended December 31, 2023(6)
Fair Value, beginning of periodTotal realized and unrealized gains (losses)PurchasesSalesIssuancesSettlementsOther(1)Transfers into Level 3(7)Transfers out of Level 3(7)Fair Value, end of periodUnrealized gains (losses) for assets still held(2)
(in thousands)
Fixed maturities, available-for-sale:
Foreign government$724 $(42)$$$$$$$$682 $(53)
Corporate securities(3)507,496 85 567,936 (39,722)(130,688)3,129 117,671 (11,564)1,014,343 (973)
Structured securities(4)104,724 (4,442)241,159 (37)(2,147)(2,222)4,537 (164,335)177,237 (4,298)
Other assets:
Fixed maturities, trading1,083 36,284 2,931 (6,250)34,048 1,225 
Equity securities28,593 (928)2,531 (1,487)28,709 (928)
Other invested assets
Short-term investments16,945 2,573 4,922 (21,322)(1,359)1,759 
Reinsurance recoverables and deposit receivables(5)(8)(9)115,886 (104,596)183,716 (2,364)192,642 (119,067)
Separate account assets4,645 408 2,216 (1,124)(160)5,985 406 
Liabilities:
Policyholders' account balances(5)(9)(3,502,096)(2,649,136)(1,653,026)106,631 (7,697,627)(368,507)
Year Ended December 31, 2023
Total realized and unrealized gains (losses)Unrealized gains (losses) for assets still held(2)
Realized investment gains (losses), netOther income (loss)Interest credited to policyholders' account balancesIncluded in other comprehensive income (loss)Net investment incomeRealized investment gains (losses), netOther income (loss)Interest credited to policyholders' account balancesIncluded in other comprehensive income (loss)
(in thousands)
Fixed maturities, available-for-sale$(2,081)$$$(2,808)$490 $(2,904)$$$(2,420)
Other assets:
Fixed maturities, trading1,080 1,225 
Equity securities(928)(928)
Other invested assets
Short-term investments1,857 (73)789 
Reinsurance recoverables and deposit receivables(8)(9)(104,596)(119,067)
Separate account assets408 406 
Liabilities:
Policyholders' account balances(9)(2,649,136)(368,507)
Year Ended December 31, 2022
Total realized and unrealized gains (losses)Unrealized gains (losses) for assets still held(2)
Realized investment gains (losses), netOther income (loss)Interest credited to policyholders' account balancesIncluded in other comprehensive income (loss)Net investment incomeRealized investment gains (losses), netOther income (loss)Interest credited to policyholders' account balancesIncluded in other comprehensive income (loss)
(in thousands)
Fixed maturities, available-for-sale$(16,829)$$$(56,470)$(242)$(14,416)$$$(59,239)
Other assets:
Equity securities(3,310)(3,872)
Short-term investments77 73 (36)73 
Reinsurance recoverables and deposit receivables(9)111,382 115,303 
Separate account assets(70)(70)
Liabilities:
Policyholders' account balances(409,912)(289,548)
(1)"Other" includes additional activity not allocated to the specific categories within the rollforward of Level 3 Assets and Liabilities.
(2)Unrealized gains or losses related to assets still held at the end of the period do not include amortization or accretion of premiums and discounts.
(3)Includes U.S. corporate private, foreign corporate public, foreign corporate private, and foreign government bonds.
(4)Includes asset-backed and commercial mortgage-backed securities.
(5)Purchases/issuances and settlements for Policyholders' account balances and Reinsurance recoverables and deposit receivables are presented net in the rollforward.
(6)Excludes MRB assets of $2,637 million and $2,367 million and MRB liabilities of $4,281 million and $5,157 million as of December 31, 2024 and 2023, respectively. See Note 10 for additional information.
(7)Transfers into or out of Level 3 are generally reported at the value as of the beginning of the quarter in which the transfers occur for any such positions still held at the end of the quarter.
(8)Prior period amounts have been updated to conform to current period presentation.
(9)Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information.
Fair Value Measurements, Nonrecurring The following tables present information for assets measured at fair value on a nonrecurring basis. The fair value measurement is nonrecurring as these assets are measured at fair value only when there is a triggering event (e.g., an evidence of impairment). Assets included in the table are those that were impaired during the respective reporting periods and that are still held as of the reporting date. The estimated fair values for these amounts were determined using significant unobservable inputs (Level 3). For the years ended December 31, 2024 and 2023, there were no triggering events.
Years Ended December 31,
202420232022
(in thousands)
Equity in earnings of operating joint venture, net of taxes
Investment in joint venture$$$(75,000)
Gains (Losses):
Other invested assets$$$(11,125)
Fair Value Disclosure Financial Instruments Not Carried at Fair Value
The tables below present the carrying amount and fair value by fair value hierarchy level of certain financial instruments that are not reported at fair value. The financial instruments presented below are reported at carrying value on the Company’s Consolidated Statements of Financial Position. In some cases, as described below, the carrying amount equals or approximates fair value.
 December 31, 2024
Fair ValueCarrying
Amount(1)
Level 1Level 2Level 3TotalTotal
 (in thousands)
Assets:
Commercial mortgage and other loans$$$7,534,909 $7,534,909 $7,759,323 
Policy loans1,541,480 1,541,480 1,541,480 
Short-term investments21,101 21,101 21,101 
Cash and cash equivalents474,415 474,415 474,415 
Accrued investment income466,394 466,394 466,394 
Reinsurance recoverables and deposit receivables2,355,489 2,355,489 2,357,292 
Receivables from parent and affiliates157,566 157,566 157,566 
Other assets203,493 203,493 203,493 
Total assets$495,516 $827,453 $11,431,878 $12,754,847 $12,981,064 
Liabilities:
Policyholders’ account balances - investment contracts$$815,520 $9,995,841 $10,811,361 $10,826,931 
Cash collateral for loaned securities121,372 121,372 121,372 
Reinsurance and funds withheld payables2,602,140 2,602,140 2,602,140 
Payables to parent and affiliates38,571 38,571 38,571 
Other liabilities849,278 31,606 880,884 880,884 
Total liabilities$$4,426,881 $10,027,447 $14,454,328 $14,469,898 
 December 31, 2023
  
Fair ValueCarrying
Amount(1)
 Level 1Level 2Level 3TotalTotal
 (in thousands)
Assets:
Commercial mortgage and other loans$$$5,918,386 $5,918,386 $6,122,721 
Policy loans1,472,677 1,472,677 1,472,677 
Short-term investments66,500 66,500 66,500 
Cash and cash equivalents470,668 24,999 495,667 495,667 
Accrued investment income333,838 333,838 333,838 
Reinsurance recoverables and deposit receivables(2)1,512,138 1,512,138 1,513,520 
Receivables from parent and affiliates184,599 184,599 184,599 
Other assets(2)80,646 80,646 80,646 
Total assets$537,168 $624,082 $8,903,201 $10,064,451 $10,270,168 
Liabilities:
Policyholders’ account balances - investment contracts$$955,647 $5,396,885 $6,352,532 $6,368,061 
Cash collateral for loaned securities218,310 218,310 218,310 
Short-term debt to affiliates176,110 176,110 180,411 
Reinsurance and funds withheld payables(2)1,517,131 1,517,131 1,517,131 
Payables to parent and affiliates16,573 16,573 16,573 
Other liabilities(2)604,730 32,423 637,153 637,153 
Total liabilities$$3,488,501 $5,429,308 $8,917,809 $8,937,639 
(1)Carrying values presented herein differ from those in the Company’s Consolidated Statements of Financial Position because certain items within the respective financial statement captions are not considered financial instruments or are out of scope under authoritative guidance relating to disclosures of the fair value of financial instruments.
(2)Prior period amounts have been updated to conform to current period presentation.